Human skin contains a population of memory T cells that support tissue homeostasis and provide protective immunity. T cell function in human skin is difficult to study due to a lack of adequate in vivo models. Thus, we utilized immunodeficient NOD-scid IL2rγ null (NSG) mice that carried in vivo-generated engineered skin (ES) and received adoptively transferred human peripheral blood mononuclear cells to follow the migration and function of circulating human memory T cells in human ES in vivo. ES were generated from human keratinocytes and fibroblasts only and initially contained no skin-resident immune cells. This reductionist system allowed us to study human T cell recruitment into non-inflamed and non-infected human skin, reflecting physiological skin conditions. Circulating human memory T cells preferentially infiltrated the human ES and these had the diverse functional profiles of T cells found in fresh human skin. Importantly, the chemokine and cytokine microenvironment found in the ES closely resembled that of non-inflamed human skin, which supports T cell maintenance and function. Upon entering the ES T cells assumed a resident memory T celllike phenotype in the absence of infection and these cutaneous T cells were activated locally upon injection of Candida albicans that was presented by autologous monocyte derived dendritic cells within the human ES. In summary, we have generated a novel mouse model with broad utility in studies of the dynamics of human cutaneous memory T cell generation, antigen-specific memory T cell responses, and the role of the skin microenvironment to skin immunity in vivo.
Introduction
As the body's outermost barrier, the skin represents a unique and complex immunological organ. As such, healthy human skin contains a large number of CD45RO+ memory T cells 1,2 that support tissue homeostasis and ensure adequate response to pathogens 3-5. A population of resident memory T (TRM) cells is found within most tissues where it remains long-term and provides protective immunity after TRM differentiation in response to primary infection 6,7. Additionally, TRM may have a protective function in organ transplantation 8 and support immuno-surveillance against melanoma 9. Cutaneous memory T cells have also been implicated in several diseases, such as cutaneous T cell lymphoma specifically mycosis fungoides 10,11. Generation and maintenance of memory T cells have been extensively studied using murine models 12, 13, [13] [14] [15] [16] , and significant advances in understanding the role of the skin microenvironment on T cell function and memory development in murine skin have been made 15,17,18. Since T cell responses are strongly influenced by the surrounding tissue 19,20, and T cells show site-specific functional and metabolic properties 18,21, it is crucial to study cutaneous immunity within its physiological compartment in vivo. However, direct translation from the murine cutaneous immune system is complicated by fundamental structural differences, as well as a lack of direct correspondence between human and murine immune cell populations 4,22-24. Due to technical and ethical limitations, studies of human memory T cell generation have mostly been restricted to ex vivo analyses and in vitro experiments, and the specific contribution of keratinocyte-and fibroblast-derived signals to cutaneous immunity in human skin remains poorly understood. A better understanding of the requirements of human cutaneous memory T cell recruitment and maintenance in human skin could lead to novel therapies for T cell mediated inflammatory diseases. However, currently existing human immune system (HIS) animal models or skin-xenograft models are complicated by unavoidable inflammation or allo-reactivity. Thus suitable in vivo models are required, that faithfully replicate conditions found in human skin under homeostatic conditions to study the requirements for the recruitment and the generation of human cutaneous memory T cell generation and their function in vivo.
Skin humanized mice in which immunodeficient mice receive skin grafts from either healthy donors or patients with skin diseases and human peripheral blood mononuclear cells (PBMC) [25] [26] [27] are currently used to study human inflammatory skin conditions in vivo, such as the rejection of skin allografts and xenogenic graft versus host disease (GvHD) development 28 . However, T cell recruitment to the skin tissue in absence of inflammation and antigenspecific activation of cutaneous T cells has been much harder to follow. Additionally, if obtained from adult donors skin grafts contain resident immune cells and have a high degree of heterogeneity in terms of immune cell infiltration 2,25,28,29, making it difficult to functionally analyze and manipulate discrete skin-tropic T cell populations.
To reduce the heterogeneity found in human skin transplants, bioengineered skin or composite skin grafts were used to study the pathogenesis of inflammatory diseases, such as psoriasis or atopic dermatitis 30,31. In these, a sheet of keratinocytes was layered over an in vitro generated dermis generated within a fibrogen or collagen matrix 32-34. However, in these models immune cells were applied locally within the engineered skin graft and recruitment of skin-tropic T cells was not studied. Interestingly, data obtained in mouse studies suggested that local skin infection can lead to seeding of the entire cutaneous surface with long lived, highly protective tissue-resident memory T cells, although the highest concentration of these cells occurred at the site of infection 35. Repeated re-infections lead to progressive accumulation of highly protective tissue-resident memory cells in non-involved skin 36.
Recruitment of human skin-tropic T cells into non-inflamed and inflamed skin is
facilitated by several chemokines and cytokines secreted by keratinocytes and fibroblasts 37-39. We utilized mice with human skin engineered only from keratinocytes and fibroblasts to create a reductionist system to study human T cell recruitment to the skin and function within human skin in absence of acute inflammation. Specifically, we used NOD-scid IL2rγnull (NSG) mice that carried in vivo-generated engineered skin (ES) and received human PBMC.
With this we could characterize phenotypic changes of circulating T cells upon entry of the skin as well as locally restricted antimicrobial responses of human cutaneous memory T cells in absence of infection or inflammation. Additionally, this model offers a new tool to dissect the role of the skin microenvironment in skin immunity in vivo.
Results

Human T cells specifically infiltrate human engineered skin in a xenograft mouse model.
To follow and characterize human T cell recruitment into the human skin in vivo, we generated engineered skin (ES) from human keratinocytes and fibroblasts that were isolated from healthy human skin and immortalized 40. ES were generated using a grafting chamber as described before 41 and allowed to heal and differentiate for a minimum of 30 days ( Fig.1a ).
Consistent with the thorough characterization of the ES by Wang et al. 41, Haematoxilin and
Eosin (H&E) staining showed that the morphology of the ES was similar to that of normal human skin with an epidermal top layer and an underlying dermal layer (Fig. 1b ). The epidermal architecture appeared multilayered and stratified, including a stratum basale, stratum spinosum, stratum granulosum and the stratum corneum, seen as flaking cells in the H&E staining ( Fig. 1b , top panel). Human type VII collagen (C7) forms a typical stainingband at the basement membrane zone (BMZ) in immunofluorescence 42, which we detected in both primary human skin and the ES. This indicated correct separation of dermis and epidermis of the in vivo generated skin ( Fig. 1b middle panel) . Staining for human cytokeratin 5/6 showed that expression is highest within the stratum basale, in line with the distinct differentiation status of keratinocytes within the epidermal layers of human skin (Fig. 1b , bottom panel).
After complete wound healing of the ES, skin-donor-matched PBMC that were isolated and stored in liquid nitrogen until use were adoptively transferred, thus creating a mouse model with a human immune system and ES that we designated huPBMC-ES-NSG ( Fig.1a ). In previous studies development of xenogeneic GvHD occurred around 5 weeks after adoptive transfer of 107 human PBMC into NSG mice 43,44. To delay the development of GvHD we reduced cell numbers to 1.8 -3x106 /mouse. The weight of experimental mice was monitored throughout the experiments to monitor potential GvHD development. Although we detected no weight loss over a period of up to 87 days following adoptive transfer of 2.5 -3x106 PBMC ( Fig. S1 ), we limited all experiments to approximately 35 days after PBMC transfer to avoid any potential convoluting effects on our studies.
Following adoptive transfer, we followed engraftment in the ES and the spleen, which serves as the main peripheral lymphoid organ in NSG mice that lack lymph nodes 45. Human CD45+ cells were detectable in the spleen after 14 days and in the ES after 21 days ( Fig. 1cd ). After a period of 18 -34 days mean levels of human CD45+ cells in spleen and ES were at >18% ( Fig. 1e , full gating strategy Fig. S2 ). The majority of human cells (>94%) in spleen and ES were CD3+ T cells ( Fig. 1f ) and the infiltration of human ES by human CD3+ cells was significantly higher compared to adjacent murine skin ( Fig. 1g ). CD4+ and CD8+ as well as TCRγδ+ T cells engrafted within the spleen and ES at levels comparable to the respective human tissues, PBMC and skin ( Fig. 1h -i). The fractions of CD4+ and CD8+ T cells in spleen and ES reflected the physiological fractions found in human PBMC and skin, respectively ( Fig. 1j ). This preservation of physiological ratios suggested a specific recruitment process or maintenance mechanism similar to these tissues in humans. Indeed, within the ES T celltrophic chemokines CCL2 46, CCL5 47, CXCL10 48, CXCL12 49 , which support the recruitment of human T cells into human skin 50, are secreted within the ES at levels comparable to those of healthy human skin ( Fig. 2a ).
However, levels of pro-inflammatory cytokines within the ES were equal or even lower to those found in healthy human skin ( Fig. 2b ), while murine skin lacks these key human chemokines and cytokines. These data suggest that the preferential infiltration of the human ES over murine skin by human T cells is not due to inflammatory signals derived from the ES but rather supported by key human chemokines produced by the ES.
Engrafted T cells share a skin-homing memory-like phenotype
Since a large proportion of T cells in human skin are CD4+ memory T cells 2,25, we assessed whether this was true for ES-infiltrating CD4+ T cells. Confirming previous studies of PBMC engraftment in NSG mice, we found that human CD4+ T cells isolated from spleens of huPBMC mice did not express markers of naïve T cells such as CCR7 and CD45RA despite being present in the ingoing PBMC population 43, and the vast majority of T cells within the ES had also assumed a CCR7-and CD45RA-memory phenotype (Fig. 3a ). Similar to the transferred PBMC, splenic T cells contained a population of CD4+ T cells that expressed cutaneous leukocyte antigen (CLA), a glycan moiety that promotes skin-homing 2. Consistent with this, CLA+ T cells accumulate within human skin 2 and these cells were also significantly enriched in the ES compared to spleen (Fig. 3b ). This indicated preferential recruitment or maintenance of skin-tropic memory T cells within the ES. In line with this, IL7 and IL15, two cytokines that support memory T cell function and maintenance in human skin 51-53, were found at equal levels within the ES and healthy human skin ( Fig. 3c ). Upon entering the ES, CD4+ T cells upregulated CD69 expression ( Fig. 3d,e ), a marker closely associated with tissue residency of human skin CD4+ T cells 25. Consistent with this, these skin-homing CLA+CD4+ T cells expressed CCR6 a receptor expressed by tissue-resident memory cells 54 (Fig. 3d,f ). Additionally, a small fraction of cutaneous CD4+ T cells expressed CD103 (Fig. 3g,h) , another marker of human skin TRM 25. It remains to be determined whether these TRM-like cells are truly resident and maintained long-term or transiently upregulated markers of tissue residency. By contrast, circulating CD62L+ memory T cells could be identified in both spleen and ES. (Fig. 3i ,j). Taken together these data indicate that engrafted CD4+ T cells show a skin-tropic, memory-like phenotype that might be supported by skin-derived cytokines.
Cutaneous and splenic T cells from huPBMC-ES-NSG mice display multifunctional profiles of T cells in human skin and blood
Next, we sought to determine whether the diverse functional phenotypes of human memory T cells were maintained within the model and thus would be suitable to study human T cell function within human skin in vivo. We assessed the function of splenic and ES-derived T cells following ex vivo stimulation and intracellular cytokine staining. The ability to produce the Th2, Th17 and Th22 cytokines IL-13, IL-17 and IL-22, respectively, were preserved in CD4+ T cells isolated from the huPBMC-ES-NSG mouse when compared to T cells from human blood and skin ( Fig. 4 a,b ; d-f). By contrast, increased percentages of CD4+ T cells isolated from the spleen and ES produced GM-CSF ( Fig. 4c ,g). Interestingly while IFNγ+CD4+ cells were increased in the spleen when compared to PBMC, the proportion of IFNγ-producing CD4+ cells within the ES was comparable to skin from healthy donors ( Fig.   4c ,h).
Analogous to the cytokine profiles of splenic and cutaneous CD4+ T cells, we assessed the cytokine secretion of CD8+ T cells isolated from spleen and ES (Fig. S3 ). The cytokine profiles of CD8+ T cells in ES and spleen were comparable to healthy human skin and PBMC with the exception of GM-CSF ( Fig. S3d) , which was increased within the ES, similar to the CD4+ T cell population.
Cutaneous CD4+ T cells are locally activated by microbial antigen
Skin CD4+ T cells play a crucial role in controlling cutaneous microbes 55. 
Particularly, the specific role of CD4+ T cells in responses against the commensal fungus
Candida albicans (C.albicans) is underscored by the fact that primary and acquired immunodeficiencies that lead to the impairment of CD4+ T cell immunity can cause pathogenic C.albicans infections 56-60. Consistent with that, the human circulating T cell pool contains skin-tropic C.albicans-specific memory T cells 61,62. To assess whether a C.albicans-specific fraction of CD4+ memory T cells was present in the adoptively transferred human PBMC, we co-cultured donor PBMC for 7 days with autologous monocyte derived dendritic cells (moDCs) that were loaded with heat killed C.albicans (HKCA) because C.albicans specific T cell responses depend on the presence of HLA-DR+ APC 16,61. We found antigen-specific proliferation, activation and cytokine secretion by HKCA stimulated CD4+ T cells when compared to co-cultures of PBMC with non-activated or LPS activated moDCs (Fig. S4 a-c). Next, we assessed whether this C.albicans-specific memory population would infiltrate the ES and mount a local antigenspecific memory T cell response upon encounter of microbial antigen. However, consistent with previous reports we found poor engraftment of HLA-DR+CD3-antigen presenting cells (APC) within the NSG mice 26 both in the spleen and ES ( Fig. S5 ). Thus, to compensate for this lack of APC we pulsed autologous moDCs with HKCA (HKCA/moDC) and injected these intradermally into the ES. LPS activated moDC (LPS/moDC) served as a control for non-C.albicans-specific activation of T cells by activated APCs. Injections were repeated 3 times within 7 days and ES and spleen were analyzed by flow cytometry one week after the last injection ( Fig. 5a ). Whereas the proportion of human CD45+ cells in the spleen remained unaffected irrespective of the treatment, a slight increase in the percentage of human CD45+ cells could be detected in ES injected with HKCA/moDC compared to LPS/moDC injected ES ( Fig. 5b ). Additionally, a significantly increased proportion of cutaneous CD4+ T cells expressed the proliferation marker Ki67 and upregulated CD25 upon injection of HKCA/moDC, indicating activation of CD4+ T cells in response to the encountered antigen ( Fig. 5c ). Similarly, CD4+ T cells produced significantly higher levels of the effector cytokines IL-17 and TNF upon injection of HKCA/moDC versus LPS/moDC ( Fig. 5d ).
Importantly, this response to HKCA/moDC within the ES was not due to pathogen-associated signals such as sensing of microbial components of the HKCA, since the injection of free HKCA failed to elicit a detectable expansion or proliferation in the spleen or ES of treated mice ( Fig. S6a,b ). Importantly, the increased proliferation and activation of CD4+ T cells in response to antigen was locally restricted to the injected ES and absent in splenic T cells ( Fig.   S6c ).
Antigen-specific T cell responses remain detectable in donor-mismatched skin tissue
These initial experiments were all performed using a completely matched system where ES, PBMC and moDC were from the same donor. However, access to skin that is matched to the PBMC of a specific patient group may present a limiting factor in studies of human cutaneous immune responses. To broaden the model's applicability, we sought to determine whether antigen-specific T cell responses could also be detected in the ES when we used donor-mismatched tissues. Therefore, we compared cutaneous CD4+ T cell responses to HKCA in donor-matched and -mismatched ES. ES were generated from two different donors (donor A or B) designated ES-NSG-A and ES-NSG-B. After complete wound healing, both recipients received PBMC that were either matched or mismatched to the ES and were injected intradermally with matched LPS/moDC or HKCA/moDC (i.e. the leukocyte populations were always HLA-matched) (Fig. 6a) . The experiments were performed in both directions with A and B being either ES or leukocyte donor.
The proliferation of CD4+ T cells within allogeneic ES was slightly but not significantly increased compared to the fully matched system (Fig. 6b) . Additionally, the levels of the activation maker HLA-DR [63] [64] [65] were comparable within the allogeneic ES tissue compared to the autologous ES in response to HKCA/moDC, and significantly increased compared to LPS/moDC injected ES (Fig. 6b ). Similarly, CD4+ T cells within the ES injected with HKCA/moDC secreted IL17 and TNF compared to LPS/moDC, indicating C.albicansspecific activation of the T cells ( Fig. 6c ). Importantly, similar to HLA-DR the proportion of IFN + CD4+ T cells were not increased within the allogeneic ES ( Fig. 6c ). Additionally, CD4:CD8 ratios remained unchanged between skin T cells from matched and mismatched HKCA/moDC injected ES suggesting a lack of CD8 expansion in response to the allogeneic keratinocytes and fibroblasts ( Fig. 6d ). Splenic CD4+ T cells showed no indication of an allogeneic response or HKCA-specific cytokine production ( Fig. S7 a-d ) and, splenic CD4+:CD8+ T cell ratios were unaltered in response to the allogeneic ES ( Fig. S7e ), indicating the absence of a systemic response.
Increased effector function of CD69+ CD4+ TRM-like T cells in response to C.albicans
In a recent study it was shown that C.albicans specific responses in murine skin was mostly mediated by a population of cutaneous CD69+CD4+ TRM cells generated after primary C.albicans infection, and a similar population was isolated from human skin 16. In line with these ex vivo findings, the CD69+CD4+ T cell population showed superior effector function within the ES following injection of HKCA/moDC ( Fig. 7) . Importantly, the CD69+ population was present within the ES prior to the application of cutaneous C.albicans in vivo ( Fig. 3e) suggesting that a C.albicans-specific CD69+ TRM-like population was seeded independently of antigen.
Discussion
Human skin contains a significant number of memory T cells that provide protective immunity and support tissue homeostasis 2,3,5,25,35. The generation of cutaneous resident TRM cells at the site of primary infection has been studied using murine models 6,7. However, suitable in vivo models to study human memory T cell generation, migration, and function of human cutaneous T cells to promote translational research were still lacking, and existing skin-humanized mouse models almost exclusively use allogeneic or inflammatory settings 25,28,30,31. Fundamental insights revealing the heterogeneity of cutaneous human memory T cell subsets were gained recently by the group of Rachel Clark, when they investigated memory T cell populations in human skin in a xenograft skin mouse model. However, the infiltration of PBMC into the skin was driven by allogeneic MHC recognition of donor APCs contained in the skin graft 25, thus reflected an inflammatory skin condition. To avoid the presence of resident immune cells within skin humanized mouse models, bioengineered skin combined with intradermal injection of in vitro generated T cell subsets and recombinant cytokines into the skin graft was used to study the pathogenesis of atopic dermatitis (AD) and psoriasis 30,31. However, these models did not follow cutaneous functions of skin-tropic T cells (i.e. a memory sub-population specialized in cutaneous immunity 66-68. In health and disease, T cell recruitment to and function within the skin depends on a variety skin-derived of chemokines and cytokines 5, and mutations leading to the loss of signaling result in impaired cutaneous T cell recruitment and/or maintenance 38,51,52. Importantly, the ES we used 41 reflected the chemokine environment found in healthy human skin, particularly chemokines and cytokines involved in T cell recruitment and activation, such as CCL2 46, CCL5 69, CXCL10 48, CXCL12 49 and T cell function and maintenance, like IL7 51,52 and IL15 51,53. In line with this, T cells migrated into the ES upon adoptive transfer of human PBMC, a process that was likely not driven by a tissue damage response, because the levels of inflammatory cytokines such as IL1 , IL1 , TNF , TNF , IL18 and IL23 were lower or at equal levels in the ES when compared to healthy human skin. This indicates that human memory T cell migration and function, as well as the impact of tissue-derived signals on immunological processes in the skin can be studied within the huPBMC-ES-NSG. Importantly, the use of ES (i.e. human skin tissue without passenger leukocytes) permits precise control over the cell populations that partake in a specific immune response.
Additionally, the ES was infiltrated by diverse subsets of memory T cells that maintained the multifunctional profiles of T cells found in human skin, and this was independent of APCs within the model. Importantly, T cells within the ES were functionally remarkably similar to T cells isolated from human skin, underlining the applicability of the huPBMC-ES-NSG model in studies of cutaneous T cell function in vivo.
As in human subjects 2, blood-derived skin-tropic CLA+CD4+ T cells accumulated within the skin when compared to splenic T cells and increase their expression of TRM markers, such as CD69 and CD103 25, underscoring the potential utility of this model to reliably study these cells in the skin in vivo. Interestingly, the generation of these CD69+ TRMlike cells occurred in absence of increased inflammatory cues or microbial antigen presentation within the ES, indicating de novo TRM generation from circulating T cells in a process that might be similar to the de novo TRM generation recently observed in patients that had received allogeneic lung transplants 8 We found that intradermal injection of moDCs loaded with antigen could substitute for poor engraftment of APC within the NSG model. Interestingly, antigen-specific T cell activation in response to HKCA presented by matched moDCs was detectable in both, autologous and allogeneic ES. Thus, access to matched blood and tissue samples might not be limiting the study of cutaneous CD4+ T cell responses in these skin-humanized mice.
Together, these data suggest that the huPBMC-ES-NSG model represents a suitable tool to study C.albicans specific local activation and memory responses of cutaneous T cells in vivo in a non-inflammatory setting. Importantly, the keratinocytes and fibroblasts used to generate ES can be cultured and manipulated using techniques such as CRISPR technology70.
Thus, the huPBMC-ES-NSG model provides a highly versatile tool to study cutaneous T cell responses and to manipulate tissue-derived signals that impact skin immunity. Additionally, the model may serve as a platform to test novel therapeutic interventions to treat cutaneous inflammation, skin tumors or autoimmune diseases.
Generation of engineered skin (ES).
Human keratinocytes and fibroblasts were isolated from human skin and immortalized using human papilloma viral oncogenes E6/E7 HPV as previously described 40. For all experiments two different skin donors were used: WT70
(indicated with square symbols in graphs), and WT85 (round symbols). Cells were cultured in Epilife (Gibco, MEPICF500) or DMEM (Gibco; 11960-044) containing 2% L-Glutamine, 1% Pen/Strep, 10% FBS, respectively. Per mouse, 1-2x106 keratinocytes were mixed 1:1 with autologous fibroblasts in 400µl MEM (Gibco; 11380037) containing 1% FBS, 1% L-Glutamine and 1% NEAA for in vivo generation of engineered skin as described 41, with slight variations, specifically the use of immortalized keratinocytes and fibroblasts.
Additionally, the silicone grafting chambers were removed completely 7 days after transplantation.
T cell isolation from skin tissues for flow cytometry. Healthy human skin and ES were digested as previously described 29. Approximately 1cm2 of skin was digested overnight in 5%CO2 at 37°C with 3ml of digestion mix containing 0.8mg/ml Collagenase Type 4 (Worthington; #LS004186) and 0.02mg/ml DNase (Sigma-Aldrich; DN25) in RPMIc. ES were digested in 1ml of digestion mix. Samples were filtered, washed and stained for flow cytometry or stimulated for intracellular cytokine staining. Approx. 3 cm2 of shaved dorsal mouse skin were harvested and single cell suspensions prepared as described 71 and stained for flow cytometry. Supplementary Table   S1 .
Histological staining of skin sections. Normal human skin, ES and adjacent murine skin were frozen in TissueTek (Sakura; TTEK). 7 µm cryosections were stained with Hemalum solution acid (Carl Rorth; T865.1) and Eosin Y aqueous solution (Sigma, 201192A). Human type VII collagen was stained by immunofluorescence using anti-human type VII collagen antibody and goat anti-rabbit A488 as secondary antibody, ProLong™ Gold Antifade 
Generation of monocyte derived dendritic cells (moDC)
moDC were generated from frozen PBMC similar to what has been described previously 72. Briefly, PBMC were thawed and monocytes adhered for 75 min at 37 °C and 5% CO2 in DC medium (RPMI 1640: 10% FBS, 2 mM L-Glutamine, 100 U/ml penicillin/streptomycin, 50 μM β-mercaptoethanol). After washing, adherent monocytes were cultured in DC medium supplemented with 50 ng/ml GM-CSF (ImmunoTools; 11343127) and 50 ng/ml IL4 (ImmunoTools; 11340047) for 7 days to generate immature DC. After 6 days, cells were harvested and re-plated in DC medium without cytokines. For activation, moDCs were cultured for 9-13 hrs with 5ng/ml LPS (Sigma-Aldrich; L2880) or 106 cells/ml heat killed Candida albicans (eubio; tlrl-hkca). 1.8-3x104 moDC/mouse were intradermally injected in 50µl PBS/mouse.
ProcartaPlex™ immunoassays from human skin and engineered skin
Human skin or ES from huPBMC-ES-NSG mice were stored at -70°C until use. Skin was taken up in PBS with Protease Inhibitor Cocktail (1:100) (Sigma-Aldrich; P8340), homogenized and filtered through 0.22µm SpinX columns. Suspensions were stored at -70°C until use. Samples were used at 8mg/ml for assay. ProcartaPlex immunoassay was performed according to the manufacturer's protocol and measured using Luminex Magpix® system. Table S1 . 
A detailed list of antibodies and reagents can be found in supplementary
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